Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-13 5:25 pm Purchase | 2025-06-06 | 13G | Tango Therapeutics, Inc. TNGX | Farallon Capital Partners, L.P. | 7,182,000 6.600% | 7,182,000 (New Position) | Filing History |
| 2025-05-20 5:59 pm Sale | 2025-05-16 | 13D | Exelixis, Inc. EXEL | Farallon Capital Partners, L.P. | 18,635,500 6.800% | -4,804,000 (-20.50%) | Filing History |
| 2025-05-15 09:24 am Purchase | 2024-12-31 | 13G | Revolution Medicines, Inc. RVMD | Farallon Capital Partners, L.P. | 13,262,045 7.900% | 1,931,000 (+17.04%) | Filing History |
| 2025-05-15 09:23 am Purchase | 2024-09-30 | 13G | Revolution Medicines, Inc. RVMD | Farallon Capital Partners, L.P. | 11,331,045 6.900% | 2,954,820 (+35.28%) | Filing History |
| 2025-05-15 09:22 am Purchase | 2024-04-12 | 13G | Revolution Medicines, Inc. RVMD | Farallon Capital Partners, L.P. | 8,376,225 5.100% | 1,626,021 (+24.09%) | Filing History |
| 2025-05-13 3:45 pm Purchase | 2025-03-31 | 13G | Beam Therapeutics Inc. BEAM | Farallon Capital Partners, L.P. | 9,972,980 9.990% | 1,733,857 (+21.04%) | Filing History |
| 2025-05-08 4:09 pm Purchase | 2025-03-31 | 13G | Perspective Therapeutics, Inc. CATX | Farallon Capital Partners, L.P. | 6,023,227 8.800% | 707,000 (+13.30%) | Filing History |
| 2025-05-07 4:25 pm Purchase | 2025-03-31 | 13G | Aramark ARMK | Farallon Capital Partners, L.P. | 16,241,996 6.100% | 2,603,656 (+19.09%) | Filing History |
| 2025-05-07 4:21 pm Sale | 2025-03-31 | 13G | Elevation Oncology, Inc. ELEV | Farallon Capital Partners, L.P. | 0 0.000% | -3,527,482 (Position Closed) | Filing History |
| 2025-03-05 5:01 pm Sale | 2025-03-05 | 13D | Exelixis, Inc. EXEL | Farallon Capital Partners, L.P. | 23,439,500 8.400% | -3,330,000 (-12.44%) | Filing History |
| 2025-02-18 3:37 pm Purchase | 2025-02-11 | 13G | Aramark ARMK | Farallon Capital Partners, L.P. | 13,638,340 5.100% | 2,001,403 (+17.20%) | Filing History |
| 2025-02-18 3:36 pm Purchase | 2025-02-11 | 13G | The New York Times Company NYT | Farallon Capital Partners, L.P. | 9,011,576 5.500% | 1,635,463 (+22.17%) | Filing History |
| 2025-02-11 5:14 pm Purchase | 2024-12-31 | 13G | Savara Inc. SVRA | Farallon Capital Partners, L.P. | 18,288,986 9.990% | 526,453 (+2.96%) | Filing History |
| 2025-02-11 12:11 pm Purchase | 2024-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Farallon Capital Partners, L.P. | 2,108,262 9.900% | 83,262 (+4.11%) | Filing History |
| 2025-02-10 2:33 pm Purchase | 2024-12-31 | 13G | AleAnna, Inc. ANNA | Farallon Capital Partners, L.P. | 1,068,400 2.600% | 1,068,400 (New Position) | Filing History |
| 2025-02-10 12:47 pm Purchase | 2024-12-31 | 13G | Forte Biosciences, Inc. FBRX | Farallon Capital Partners, L.P. | 221,027 3.400% | 69,287 (+45.66%) | Filing History |
| 2025-02-10 09:00 am Purchase | 2024-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Farallon Capital Partners, L.P. | 5,956,488 9.990% | 191,379 (+3.32%) | Filing History |
| 2025-02-05 7:30 pm Purchase | 2024-12-31 | 13G | Beam Therapeutics Inc. BEAM | Farallon Capital Partners, L.P. | 8,239,123 9.900% | 31,000 (+0.38%) | Filing History |
| 2025-02-05 5:23 pm Sale | 2024-12-31 | 13G | The New York Times Company NYT | Farallon Capital Partners, L.P. | 7,376,113 4.500% | -2,100,678 (-22.17%) | Filing History |
| 2025-02-05 4:28 pm Unchanged | 2024-12-31 | 13G | Elevation Oncology, Inc. ELEV | Farallon Capital Partners, L.P. | 3,527,482 6.000% | 0 (Unchanged) | Filing History |